PLEASE NOTE :: We are still open for business and accepting new clients. To protect your safety in response to the threats of COVID-19, we are offering new and current clients the ability to meet with us in person, via telephone or through video conferencing. Please call our office to discuss your options.

Alexander Law

Call Or Text For A Free Case Evaluation

The Consumer Product Safety Commission (CPSC) recently issued a press release about a recall involving prescription drugs with dangerous packaging. According to the CPSC, Sandoz and Novartis are recalling prescription drug blister packages due to failing to meet child-restraint closure requirements. Apparently, the prescription drug packaging in question is not child resistant as required by the Poison Prevention Packaging Act, which poses a poisoning risk of swallowed by children. At this time, approximately 470,000 units are being impacted by this recall.

Details of The Sandoz and Novartis Drug Recall

The recall involves blister packages of a variety of prescription drugs from Novartis and Sandoz. These packages hold three to 10 tablets per blister card. So far, there has been one report of a child ingesting haloperidol from a blister pack. These meds were prescribed nationwide between September 2016 and June 2018. Listed below are the drugs that are currently being impacted by this Novartis and Sandoz recall.

Novartis Drugs Being Recalled

  • Zofran ODT 4 mg
  • Zofran ODT 8 mg
  • Entresto (sacubitril/ valsartan) 24 mg/26 mg
  • Entresto (sacubitril/ valsartan) 49 mg/ 51 mg
  • Entresto (sacubitril/ valsartan) 97 mg/ 103 mg

Sandoz Drugs Being Recalled

  • Azithromycin Tablets 250 mg
  • Donepezil ODT Tablets 5 mg
  • Donepezil ODT Tablets 10 mg
  • Haloperidol Tablets 0.5 mg
  • Haloperidol Tablets 1 mg
  • Haloperidol Tablets 2 mg
  • Haloperidol Tablets 5 mg
  • Haloperidol Tablets 10 mg
  • Imipramine HCl Tablets 25 mg
  • Imipramine HCl Tablets 50 mg
  • Isosorbide Dinitrate (ISDN) Tablets 10 mg
  • Isosorbide Dinitrate (ISDN) Tablets 20 mg
  • Naratriptan Tablets 2.5 mg
  • Ondansetron Tablets 8 mg
  • Ondansetron ODT 4 mg
  • Ondansetron ODT 8 mg
  • Perphenazine Tablets 2 mg
  • Perphenazine Tablets 4 mg
  • Perphenazine Tablets 8 mg
  • Risperidone ODT 0.5 mg
  • Risperidone ODT 1 mg
  • Risperidone ODT 2 mg
  • Risperidone ODT 3 mg
  • Risperidone ODT 4 mg

Defective Drug Blister Packs and Child Safety

Novartis and Sandoz are urging consumers to immediately secure the blister cards associated with this recall and keep them out if sight and out of reach of children. Consumers with these prescription drugs should call the manufacturers, either Novartis or Sandoz, for further instructions. They also advise continuing use with the medications as directed once the packages have been secured away from children.

Alexander Law Group, LLP attorneys are always ready to answer questions and share the results of our research and experience with the public. As safety lawyers, our goal is to make a difference for our clients and our community.